Procaps Group Corp (PROC) Company Cash Funds

Official company branding of Procaps Group S.A. (PROC)

Procaps Group S.A. (PROC) dominance in softgel capsule production provides significant pricing power, as evidenced by the cash balance on the company's books. Stable demand for pharmaceutical products reduces business cyclicality, while the current value of 0.00 captures the metric level. However, turnover in financial personnel and audit complexities create operational risks that impact the company's liquidity dynamics.

Company Liquid Assets: Procaps Group Corp (PROC) for 07/04/2022 - 02/16/2025

PROC (Procaps Group): analytical breakdowns and indicator data

Fundamental valuation:PROC Procaps Group
Brand item of Procaps

This indicator captures the actual cash balances on the accounts of Procaps Group S.A. (PROC) at the close of the trading day. It measures real-time solvency and the business's ability to withstand external shocks. By analyzing the company's cash liquidity, an investor can identify hidden capital outflows and the efficiency of resource management. While excess cash reduces shareholder returns, it guarantees operational stability. For Procaps Group S.A. (PROC), this reserve is critical amid a change in financial management and current auditing delays.

Competitors of Procaps Group S.A. (PROC)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Reserve Lipella Pharmaceuticals Inc|OPTN: Company Cash Volume|Pieris - Company Cash Balance|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance